CVR: 36899069
Previous names: NMD Pharma ApS
EUR -26,063,175
Gross profit
Net result: EUR -32,985,370
LUNDBECKFOND INVEST A/S, Novo Holdings A/S
3 more
CVR · view ownership and management
Owner registered: INKEF Holding Coöperatief U.A.
CVR · 30/06/2026
View the full event history
NMD Pharma A/S is a Danish company of the type Aktieselskab based in Aarhus N, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named NMD Pharma ApS. The management consists of Thomas Holm Pedersen. The company's owners include LUNDBECKFOND INVEST A/S, Novo Holdings A/S and Roche Finance Ltd.. The company has 18 employees (2018). In 2025, the company reported a gross profit of EUR -26,063,175 and a net result of EUR -32,985,370 compared with EUR -32,253,700 the year before. Equity in the 2025 report amounted to EUR 12,410,475.
Selskabets formål er at drive virksomhed med forskning og udarbejdelse af stoffer, herunder til medicinalindustrien, samt enhver i forbindelse hermed stående virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -26.1 mio. EUR | -33 mio. EUR | 23 mio. EUR | 12.4 mio. EUR | 49 | |
| 202401/01/2024 – 31/12/2024 | -27.9 mio. EUR | -32.3 mio. EUR | 39.4 mio. EUR | 35.4 mio. EUR | 36 | |
| 202301/01/2023 – 31/12/2023 | -19.2 mio. EUR | -22.4 mio. EUR | 46.4 mio. EUR | 42.7 mio. EUR | 31 | |
| 202201/01/2022 – 31/12/2022 | -9.5 mio. EUR | -12.3 mio. EUR | 27.1 mio. EUR | 25.1 mio. EUR | 26 | |
| 202101/01/2021 – 31/12/2021 | -11 mio. EUR | -13.6 mio. EUR | 4.9 mio. EUR | 2.6 mio. EUR | 26 | |
| 202001/01/2020 – 31/12/2020 | -7.9 mio. EUR | -9.9 mio. EUR | 11.5 mio. EUR | 9.2 mio. EUR | 22 | |
| 201901/01/2019 – 31/12/2019 | -7.1 mio. EUR | -8.5 mio. EUR | - | 140 t. EUR | 17 | |
| 201801/01/2018 – 31/12/2018 | -4.7 mio. EUR | -5.5 mio. EUR | - | 88 t. EUR | 14 | |
| 201701/01/2017 – 31/12/2017 | -17.9 mio. | -21.9 mio. | 21.3 mio. | -8.7 mio. | 13 | |
| 201601/01/2016 – 31/12/2016 | -6.4 mio. | -6.9 mio. | 14.5 mio. | 13.1 mio. | 5 |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNMD Pharma A/S was founded on 7 May 2015.
NMD Pharma A/S is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
NMD Pharma A/S had 18 employees in 2018 according to the Danish CVR register.
The owners of NMD Pharma A/S include LUNDBECKFOND INVEST A/S, Novo Holdings A/S and Roche Finance Ltd..
In 2025, NMD Pharma A/S reported a gross profit of EUR -26,063,175.
The management of NMD Pharma A/S consists of Thomas Holm Pedersen.
Claim this page to add your logo and social links. Free to get started.
As of June 30, 2026, is registered as an owner of NMD Pharma A/S with an ownership share of 15%.
NMD Pharma A/S has published its annual report for 2025. Gross profit came to DKK -26,063,175, and the net result was DKK -32,985,370.
As of May 8, 2026, Mahieddine El Mahdi Aïnouche has joined the board of directors of NMD Pharma A/S.
As of May 8, 2026, Sabine Kohar Dandiguian has left the board of directors of NMD Pharma A/S.
As of April 2, 2026, Anja Ulrike Harmeier has joined the board of directors of NMD Pharma A/S.
As of April 2, 2026, David William Evans has left the board of directors of NMD Pharma A/S.
As of August 12, 2025, is registered as an owner of NMD Pharma A/S with an ownership share of 10%.
As of August 12, 2025, is registered as an owner of NMD Pharma A/S with an ownership share of 33%.
NMD Pharma A/S has published its annual report for 2024. Gross profit came to DKK -27,874,344, and the net result was DKK -32,253,700.
As of May 1, 2025, Ivan Andreevich Burkov has joined the board of directors of NMD Pharma A/S.
As of May 1, 2025, Simone Botti has left the board of directors of NMD Pharma A/S.
As of February 13, 2025, João Carlos Ribas de Almeida has joined the board of directors of NMD Pharma A/S.
As of February 13, 2025, Morten Døssing has left the board of directors of NMD Pharma A/S.
NMD Pharma A/S has published its annual report for 2023. Gross profit came to DKK -19,182,079, and the net result was DKK -22,401,436.
As of November 13, 2023, Thomas Holm Pedersen has joined the board of directors of NMD Pharma A/S.
As of October 13, 2023, LUNDBECKFOND INVEST A/S is registered as an owner of NMD Pharma A/S with an ownership share of 15%.
As of October 13, 2023, Novo Holdings A/S is registered as an owner of NMD Pharma A/S with an ownership share of 15%.
NMD Pharma A/S has published its annual report for 2022. Gross profit came to DKK -9,480,436, and the net result was DKK -12,323,989.
As of May 1, 2023, Simone Botti has joined the board of directors of NMD Pharma A/S.
As of May 1, 2023, Roel Bulthuis has left the board of directors of NMD Pharma A/S.
As of December 15, 2022, Michael Thomas Heffernan has joined the board of directors of NMD Pharma A/S.
As of December 15, 2022, Patrick Volkert Jozef Johannes Vink has left the board of directors of NMD Pharma A/S.
NMD Pharma A/S has published its annual report for 2021. Gross profit came to DKK -11,029,051, and the net result was DKK -13,614,082.
As of February 4, 2022, Sabine Kohar Dandiguian has joined the board of directors of NMD Pharma A/S.
As of February 4, 2022, David William Evans has joined the board of directors of NMD Pharma A/S.
As of February 4, 2022, Monique Claude Schiersing has left the board of directors of NMD Pharma A/S.
NMD Pharma A/S has published its annual report for 2020. Gross profit came to DKK -7,870,124, and the net result was DKK -9,928,027.
As of June 8, 2020, Monique Claude Schiersing has joined the board of directors of NMD Pharma A/S.
NMD Pharma A/S has published its annual report for 2019. Gross profit came to DKK -7,132,039, and the net result was DKK -8,501,273.
As of April 23, 2020, Roel Bulthuis has joined the board of directors of NMD Pharma A/S.
As of April 23, 2020, Anja Ulrike DR Harmeier has left the board of directors of NMD Pharma A/S.
As of April 23, 2020, Fiona MacLaughlin has left the board of directors of NMD Pharma A/S.
As of August 10, 2019, Paul Brian Little has left the board of directors of NMD Pharma A/S.
NMD Pharma A/S has published its annual report for 2018. Gross profit came to DKK -4,661,848, and the net result was DKK -5,542,829.
As of May 23, 2019, Jeremy Paul Springhorn has joined the board of directors of NMD Pharma A/S.
As of May 23, 2019, Fiona MacLaughlin has joined the board of directors of NMD Pharma A/S.
As of May 23, 2019, Lucas Antoine de Breed has left the board of directors of NMD Pharma A/S.
As of December 21, 2018, EY Godkendt Revisionspartnerselskab has been appointed auditor of NMD Pharma A/S.
As of December 21, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of NMD Pharma A/S.
As of November 19, 2018, Paul Brian Little has joined the board of directors of NMD Pharma A/S.
NMD Pharma A/S has published its annual report for 2017. Gross profit came to DKK -17,857,762, and the net result was DKK -21,883,435.
As of March 5, 2018, Lucas Antoine de Breed has joined the board of directors of NMD Pharma A/S.
As of March 5, 2018, Anja Ulrike DR Harmeier has joined the board of directors of NMD Pharma A/S.
As of March 5, 2018, Claus Elsborg Olesen has left the board of directors of NMD Pharma A/S.
On March 5, 2018, the company changed its name from NMD Pharma ApS to NMD Pharma A/S.
NMD Pharma A/S has published its annual report for 2016. Gross profit came to DKK -6,371,806, and the net result was DKK -6,872,801.
As of February 15, 2017, Morten Døssing has joined the board of directors of NMD Pharma A/S.
As of February 15, 2017, Stephan Christgau has left the board of directors of NMD Pharma A/S.
As of June 2, 2016, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of NMD Pharma A/S.
As of June 2, 2016, Claus Elsborg Olesen has joined the board of directors of NMD Pharma A/S.
As of June 2, 2016, Christian Ellebæk Elling has joined the board of directors of NMD Pharma A/S.
As of June 2, 2016, Stephan Christgau has joined the board of directors of NMD Pharma A/S.
As of June 2, 2016, Patrick Volkert Jozef Johannes Vink has joined the board of directors of NMD Pharma A/S.
NMD Pharma A/S has published its interim report for the period May 7, 2015 – December 31, 2015.
As of May 7, 2015, Thomas Holm Pedersen is registered as director of NMD Pharma A/S.
NMD Pharma A/S was founded on May 7, 2015.
Companies in the same industry and area
CVR 26119898
CVR 41058439
CVR 46253272
CVR 10403782
CVR 42532622
